Carola Lübbing-Raukohl – new head of communications at the Paul-Ehrlich-Institut
As per 15 October 2017, Carola Lübbing-Raukohl became the Head of Press and Information Office at the Paul-Ehrlich-Institut (PEI). In her position, she is the speaker of the institute and is responsible for its internal and external communication.
Her work, among other things, focuses on the further development of digital channels including social media. She reports directly to the president of the PEI, Professor Dr Klaus Cichutek.
Carola Lübbing-Raukohl had previously worked at Deutsche Börse where she last held the position as the Head of Digital Channels & Editorial. Dr Susanne Stöcker continues to strengthen the team as press speaker.
Telefon: +49 6103 77 1030
The Paul-Ehrlich-Institut, the Federal Institute for Vaccines and Biomedicines, in Langen near Frankfurt/Main is a senior federal authority reporting to the Federal Ministry of Health (Bundesministerium für Gesundheit, BMG). It is responsible for the research, assessment, and marketing authorisation of biomedicines for human use and immunological veterinary medicinal products. Its remit also includes the authorisation of clinical trials and pharmacovigilance, i.e. recording and evaluation of potential adverse effects.
Other duties of the institute include official batch control, scientific advice and inspections. In-house experimental research in the field of biomedicines and life science form an indispensable basis for the manifold tasks performed at the institute.
The Paul-Ehrlich-Institut, with its roughly 800 members of staff, also has advisory functions nationally (federal government, federal states (Länder)), and internationally (World Health Organisation, European Medicines Agency, European Commission, Council of Europe etc.).